Patients discrimination between

This generates problems of discrimination between some patients and others, which can on occasions amount to a major political problem. It may be more normal to assume that, once a drug is financed, it will be consumed by a wide variety of patients. Furthermore, it may not be feasible in practice to discriminate between patients for whom the treatment is highly effective and those for whom it is less so. 

Beck Depression Inventory. The Beck Depression Inventory (Beck) test may be used to measure the depth of depression as a rapid screen for depressed patients. It is a self-rating scale of 21 items (13 in a shortened form), with each item rated on a four-point scale. It measures the immediate present and has been used in antidepressant medicine trials. The original 21-item scale can be completed in about 10 minutes and the test is able to discriminate between anxiety and depression. No subtests are present in the Beck. 

The interactions of depressed persons with others play an important role in the etiology of depression. According to Coyne (1976) depressed persons elicit support behaviors intermixed with rejection from others. Brown (1994) found that depression chronicity is related to a lack of social support. We investigated whether observable behaviors (which may reflect support-seeking and giving) in an interaction of depressed patients and others (i.e., partner and stranger) (1) predict depression outcome and (2) discriminate between patient and others interactional patterns. 

For MG7-Ag, similar results were obtained [32] A direct comparison was carried out with commercially available kits for several tumor markers and an IPCR of MG7-Ag. The IPCR assay detected 81.4% seropositive samples, whereas other tests varied between 48.8% (MG7Ag with IRMA detection) and 33.7% (CEA-RIA) correct identifications of gastric carcinoma patients. IPCR additionally allowed for the discrimination between patients both with... 

A microfluidic device has been developed, which allows hybridization in 15 min and was able to discriminate between four Staphylococcus strains (134). A similar device has also been developed for cell lysis (135). The goal of these devices is to allow a clinical lab to take a patient specimen dispense it into a cassette and have DNA extraction, labeling, hybridization, and scanning occur automatically (136). 

Neither 10 mg nor 30 mg of oxazepam affected the reaction time tasks in the patients, whereas the controls had dose-related impairment. The memory impairing effects did not differ significantly. In contrast to the controls, the patients could not discriminate between a 10 mg and a 30 mg dose, as assessed by visual analogue scales and the Spielberger State-Trait Anxiety Inventory Version 1, which might indicate a placebo effect of 10 mg in patients. The authors concluded that additional doses of oxazepam during long-term treatment have pronounced effects, even after daily use for more than 10 years. 

Systemic variation as well as inherent biological variation arising from patient-to-patient, culture-to-culture differences, etc., can be clearly differentiated from induced biological changes. The DIGE system allows discrimination between true biological differences on the one hand and systemic as well as interindividual differences on the other. 

---